- Gebundenes Buch
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung
Cancer in pregnancy presents physicians and their patients with a major dilemma. The urge to use the highest tolerable doses of chemotherapy, high doses of irradiation and surgery, has to be weighed carefully against their risks to the unborn baby. This book is the very first to attempt to quantify these risks, and to provide physicians with a core of knowledge that will be very relevant to making sound clinical decisions in the face of sometimes conflicting interests.
Andere Kunden interessierten sich auch für
- Cancer in Pregnancy and Lactation128,99 €
- Lyliane RosettaVariability in Human Fertility141,99 €
- Altchek's Diagnosis and Management of Ovarian Disorders165,99 €
- Botros R. M. B. RizkOvarian Hyperstimulation Syndrome135,99 €
- R. Bentley / C. G. Mascie-Taylor (eds.)Infertility in the Modern World132,99 €
- Cancer and Sexual Health184,99 €
- J. Horsky / J. Presl (eds.)Ovarian Function and Its Disorders: Diagnosis and Therapy109,99 €
-
-
-
Cancer in pregnancy presents physicians and their patients with a major dilemma. The urge to use the highest tolerable doses of chemotherapy, high doses of irradiation and surgery, has to be weighed carefully against their risks to the unborn baby. This book is the very first to attempt to quantify these risks, and to provide physicians with a core of knowledge that will be very relevant to making sound clinical decisions in the face of sometimes conflicting interests.
Produktdetails
- Produktdetails
- Verlag: Cambridge University Press
- Seitenzahl: 236
- Erscheinungstermin: 21. März 2003
- Englisch
- Abmessung: 235mm x 157mm x 19mm
- Gewicht: 542g
- ISBN-13: 9780521471763
- ISBN-10: 0521471761
- Artikelnr.: 22025764
- Verlag: Cambridge University Press
- Seitenzahl: 236
- Erscheinungstermin: 21. März 2003
- Englisch
- Abmessung: 235mm x 157mm x 19mm
- Gewicht: 542g
- ISBN-13: 9780521471763
- ISBN-10: 0521471761
- Artikelnr.: 22025764
Preface G. Koren, M. Lishner and D. Farine; Introduction; 1. Cancer in
pregnancy: Identification of unanswered questions on maternal and fetal
risks G. Koren, L. Weiner, M. Lishner, D. Zemelickis and J Finnegan; 2. The
pregnant patient with malignant disease - maternal fetal conflict D. Farine
and E. N. Kelly; 3. Changes in drug disposition during pregnancy and its
clinical implications G. Koren; 4. The role of the placenta in
biotransformation of carcinogenic compounds L. Derewlany and G. Koren; 5.
Antepartum fetal monotoring in the oncologic patient Y. Ezra and K. Panter;
6. The Toronto Study Group - Methodological Notes; 7. Motherisk - The
process of counselling in reproductive toxicology G. Koren and A.
Pastuszak; Specific Tumors During Pregnancy: 8. Maternal and fetal outcome
following breast cancer in pregnancy D. Zemlickis, M. Lishner, P.
Degendorfer, T. Panzarella, B. Burke, S. B. Sutcliffe and G. Koren; 9.
Maternal and fetal outcome following Hodgkin's disease in pregnancy M.
Lishner, D. Zemlickis, P. Degendorfer, T. Panzarella, S. B. Sutcliffe and
G. Koren; 10. Non-Hodgkin's lymphoma and pregnancy D. Zemlickis, M.
Lishner, S. B. Sutcliffe and G. Koren; 11. Maternal and fetal outcome
following invasive cervical cancer in pregnancy M. Lishner, D. Zemlickis,
P. Degendorfer, T. Panzarella, S. B. Sutcliffe and G. Koren; 12. Pregnancy
and ovarian cancer M. Lishner and G. Koren; 13. Malignant melanoma and
pregnancy M. Ravid and M. Lishner; 14. Leukemia during pregnancy M.
Lishner; Fetal Effects of Cancer and its Treatment: 15. Prenatal
irradiation and cancer Y. Bentur; 16. Review of fetal effects of cancer
chemotherapeutic agents D. Zemlickis, M. Lishner and G. Koren; 17. Fetal
outcome folowing in utero exposure to cancer chemotherapy - The Toronto
study D. Zemlickis, M. Lishner, P. Degendorfer, T. Panzarella, S. B.
Sutcliffe and G. Koren; 18. Intrauterine causes of tumors in later life G.
Koren; 19. Fetal tumors P. McParland; Index.
pregnancy: Identification of unanswered questions on maternal and fetal
risks G. Koren, L. Weiner, M. Lishner, D. Zemelickis and J Finnegan; 2. The
pregnant patient with malignant disease - maternal fetal conflict D. Farine
and E. N. Kelly; 3. Changes in drug disposition during pregnancy and its
clinical implications G. Koren; 4. The role of the placenta in
biotransformation of carcinogenic compounds L. Derewlany and G. Koren; 5.
Antepartum fetal monotoring in the oncologic patient Y. Ezra and K. Panter;
6. The Toronto Study Group - Methodological Notes; 7. Motherisk - The
process of counselling in reproductive toxicology G. Koren and A.
Pastuszak; Specific Tumors During Pregnancy: 8. Maternal and fetal outcome
following breast cancer in pregnancy D. Zemlickis, M. Lishner, P.
Degendorfer, T. Panzarella, B. Burke, S. B. Sutcliffe and G. Koren; 9.
Maternal and fetal outcome following Hodgkin's disease in pregnancy M.
Lishner, D. Zemlickis, P. Degendorfer, T. Panzarella, S. B. Sutcliffe and
G. Koren; 10. Non-Hodgkin's lymphoma and pregnancy D. Zemlickis, M.
Lishner, S. B. Sutcliffe and G. Koren; 11. Maternal and fetal outcome
following invasive cervical cancer in pregnancy M. Lishner, D. Zemlickis,
P. Degendorfer, T. Panzarella, S. B. Sutcliffe and G. Koren; 12. Pregnancy
and ovarian cancer M. Lishner and G. Koren; 13. Malignant melanoma and
pregnancy M. Ravid and M. Lishner; 14. Leukemia during pregnancy M.
Lishner; Fetal Effects of Cancer and its Treatment: 15. Prenatal
irradiation and cancer Y. Bentur; 16. Review of fetal effects of cancer
chemotherapeutic agents D. Zemlickis, M. Lishner and G. Koren; 17. Fetal
outcome folowing in utero exposure to cancer chemotherapy - The Toronto
study D. Zemlickis, M. Lishner, P. Degendorfer, T. Panzarella, S. B.
Sutcliffe and G. Koren; 18. Intrauterine causes of tumors in later life G.
Koren; 19. Fetal tumors P. McParland; Index.
Preface G. Koren, M. Lishner and D. Farine; Introduction; 1. Cancer in
pregnancy: Identification of unanswered questions on maternal and fetal
risks G. Koren, L. Weiner, M. Lishner, D. Zemelickis and J Finnegan; 2. The
pregnant patient with malignant disease - maternal fetal conflict D. Farine
and E. N. Kelly; 3. Changes in drug disposition during pregnancy and its
clinical implications G. Koren; 4. The role of the placenta in
biotransformation of carcinogenic compounds L. Derewlany and G. Koren; 5.
Antepartum fetal monotoring in the oncologic patient Y. Ezra and K. Panter;
6. The Toronto Study Group - Methodological Notes; 7. Motherisk - The
process of counselling in reproductive toxicology G. Koren and A.
Pastuszak; Specific Tumors During Pregnancy: 8. Maternal and fetal outcome
following breast cancer in pregnancy D. Zemlickis, M. Lishner, P.
Degendorfer, T. Panzarella, B. Burke, S. B. Sutcliffe and G. Koren; 9.
Maternal and fetal outcome following Hodgkin's disease in pregnancy M.
Lishner, D. Zemlickis, P. Degendorfer, T. Panzarella, S. B. Sutcliffe and
G. Koren; 10. Non-Hodgkin's lymphoma and pregnancy D. Zemlickis, M.
Lishner, S. B. Sutcliffe and G. Koren; 11. Maternal and fetal outcome
following invasive cervical cancer in pregnancy M. Lishner, D. Zemlickis,
P. Degendorfer, T. Panzarella, S. B. Sutcliffe and G. Koren; 12. Pregnancy
and ovarian cancer M. Lishner and G. Koren; 13. Malignant melanoma and
pregnancy M. Ravid and M. Lishner; 14. Leukemia during pregnancy M.
Lishner; Fetal Effects of Cancer and its Treatment: 15. Prenatal
irradiation and cancer Y. Bentur; 16. Review of fetal effects of cancer
chemotherapeutic agents D. Zemlickis, M. Lishner and G. Koren; 17. Fetal
outcome folowing in utero exposure to cancer chemotherapy - The Toronto
study D. Zemlickis, M. Lishner, P. Degendorfer, T. Panzarella, S. B.
Sutcliffe and G. Koren; 18. Intrauterine causes of tumors in later life G.
Koren; 19. Fetal tumors P. McParland; Index.
pregnancy: Identification of unanswered questions on maternal and fetal
risks G. Koren, L. Weiner, M. Lishner, D. Zemelickis and J Finnegan; 2. The
pregnant patient with malignant disease - maternal fetal conflict D. Farine
and E. N. Kelly; 3. Changes in drug disposition during pregnancy and its
clinical implications G. Koren; 4. The role of the placenta in
biotransformation of carcinogenic compounds L. Derewlany and G. Koren; 5.
Antepartum fetal monotoring in the oncologic patient Y. Ezra and K. Panter;
6. The Toronto Study Group - Methodological Notes; 7. Motherisk - The
process of counselling in reproductive toxicology G. Koren and A.
Pastuszak; Specific Tumors During Pregnancy: 8. Maternal and fetal outcome
following breast cancer in pregnancy D. Zemlickis, M. Lishner, P.
Degendorfer, T. Panzarella, B. Burke, S. B. Sutcliffe and G. Koren; 9.
Maternal and fetal outcome following Hodgkin's disease in pregnancy M.
Lishner, D. Zemlickis, P. Degendorfer, T. Panzarella, S. B. Sutcliffe and
G. Koren; 10. Non-Hodgkin's lymphoma and pregnancy D. Zemlickis, M.
Lishner, S. B. Sutcliffe and G. Koren; 11. Maternal and fetal outcome
following invasive cervical cancer in pregnancy M. Lishner, D. Zemlickis,
P. Degendorfer, T. Panzarella, S. B. Sutcliffe and G. Koren; 12. Pregnancy
and ovarian cancer M. Lishner and G. Koren; 13. Malignant melanoma and
pregnancy M. Ravid and M. Lishner; 14. Leukemia during pregnancy M.
Lishner; Fetal Effects of Cancer and its Treatment: 15. Prenatal
irradiation and cancer Y. Bentur; 16. Review of fetal effects of cancer
chemotherapeutic agents D. Zemlickis, M. Lishner and G. Koren; 17. Fetal
outcome folowing in utero exposure to cancer chemotherapy - The Toronto
study D. Zemlickis, M. Lishner, P. Degendorfer, T. Panzarella, S. B.
Sutcliffe and G. Koren; 18. Intrauterine causes of tumors in later life G.
Koren; 19. Fetal tumors P. McParland; Index.